Abstract

Retinoic acid (RA) is an essential signaling molecule for cardiac development and plays a protective role in the heart after myocardial infarction (MI). In both cases, the effect of RA signaling on cardiomyocytes, the principle cell type of the heart, has been reported to be indirect. Here we have developed an inducible murine transgenic RA-reporter line using CreERT2 technology that permits lineage tracing of RA-responsive cells and faithfully recapitulates endogenous RA activity in multiple organs during embryonic development. Strikingly, we have observed a direct RA response in cardiomyocytes during mid-late gestation and after MI. Ablation of RA signaling through deletion of the Aldh1a1/a2/a3 genes encoding RA-synthesizing enzymes leads to increased cardiomyocyte apoptosis in adults subjected to MI. RNA sequencing analysis reveals Tgm2 and Ace1, two genes with well-established links to cardiac repair, as potential targets of RA signaling in primary cardiomyocytes, thereby providing novel links between the RA pathway and heart disease.

Data availability

RNA sequencing data have been deposited in GEO under accession code GSE161429

The following data sets were generated

Article and author information

Author details

  1. Fabio Da Silva

    Inserm, CNSR, iBV, Université Côte d'Azur, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8983-2238
  2. Fariba Jian Motamedi

    Inserm, CNSR, iBV, Université Côte d'Azur, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Lahiru Chamara Weerasinghe Arachchige

    Inserm, CNSR, iBV, Université Côte d'Azur, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4492-8946
  4. Amelie Tison

    Inserm, CNSR, iBV, Université Côte d'Azur, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Stephen T Bradford

    Inserm, CNSR, iBV, Université Côte d'Azur, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9508-3894
  6. Jonathan Lefebvre

    Inserm, CNSR, iBV, Université Côte d'Azur, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Pascal Dolle

    Inserm U1258, UNISTRA CNRS, UMR7104, IGBMC, Illkirch, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Norbert B Ghyselinck

    Inserm U1258, UNISTRA CNRS, UMR7104, IGBMC, Illkirch, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Kay D Wagner

    Inserm, CNSR, iBV, Université Côte d'Azur, Nice, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Andreas Schedl

    Inserm, CNSR, iBV, Université Côte d'Azur, Nice, France
    For correspondence
    Andreas.Schedl@unice.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9380-7396

Funding

Fondation de France (00056856)

  • Andreas Schedl

Fondation ARC pour la Recherche sur le Cancer (SL22020605297)

  • Andreas Schedl

Agence Nationale de la Recherche (ANR-11-LABX-0028-01)

  • Fabio Da Silva
  • Andreas Schedl

Ligue Contre le Cancer (equipe labelisée 2018)

  • Andreas Schedl

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Edward E Morrisey, University of Pennsylvania, United States

Ethics

Animal experimentation: All animal work was conducted according to national and international guidelines and was approved by the local ethics committee (PEA-NCE/2013/88).

Version history

  1. Preprint posted: December 4, 2020 (view preprint)
  2. Received: March 14, 2021
  3. Accepted: October 7, 2021
  4. Accepted Manuscript published: October 8, 2021 (version 1)
  5. Version of Record published: October 21, 2021 (version 2)

Copyright

© 2021, Da Silva et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,400
    views
  • 275
    downloads
  • 14
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Fabio Da Silva
  2. Fariba Jian Motamedi
  3. Lahiru Chamara Weerasinghe Arachchige
  4. Amelie Tison
  5. Stephen T Bradford
  6. Jonathan Lefebvre
  7. Pascal Dolle
  8. Norbert B Ghyselinck
  9. Kay D Wagner
  10. Andreas Schedl
(2021)
Retinoic acid signaling is directly activated in cardiomyocytes and protects mouse hearts from apoptosis after myocardial infarction
eLife 10:e68280.
https://doi.org/10.7554/eLife.68280

Share this article

https://doi.org/10.7554/eLife.68280

Further reading

    1. Computational and Systems Biology
    2. Developmental Biology
    Gang Xue, Xiaoyi Zhang ... Zhiyuan Li
    Research Article

    Organisms utilize gene regulatory networks (GRN) to make fate decisions, but the regulatory mechanisms of transcription factors (TF) in GRNs are exceedingly intricate. A longstanding question in this field is how these tangled interactions synergistically contribute to decision-making procedures. To comprehensively understand the role of regulatory logic in cell fate decisions, we constructed a logic-incorporated GRN model and examined its behavior under two distinct driving forces (noise-driven and signal-driven). Under the noise-driven mode, we distilled the relationship among fate bias, regulatory logic, and noise profile. Under the signal-driven mode, we bridged regulatory logic and progression-accuracy trade-off, and uncovered distinctive trajectories of reprogramming influenced by logic motifs. In differentiation, we characterized a special logic-dependent priming stage by the solution landscape. Finally, we applied our findings to decipher three biological instances: hematopoiesis, embryogenesis, and trans-differentiation. Orthogonal to the classical analysis of expression profile, we harnessed noise patterns to construct the GRN corresponding to fate transition. Our work presents a generalizable framework for top-down fate-decision studies and a practical approach to the taxonomy of cell fate decisions.

    1. Developmental Biology
    2. Evolutionary Biology
    Zhuqing Wang, Yue Wang ... Wei Yan
    Research Article

    Despite rapid evolution across eutherian mammals, the X-linked MIR-506 family miRNAs are located in a region flanked by two highly conserved protein-coding genes (SLITRK2 and FMR1) on the X chromosome. Intriguingly, these miRNAs are predominantly expressed in the testis, suggesting a potential role in spermatogenesis and male fertility. Here, we report that the X-linked MIR-506 family miRNAs were derived from the MER91C DNA transposons. Selective inactivation of individual miRNAs or clusters caused no discernible defects, but simultaneous ablation of five clusters containing 19 members of the MIR-506 family led to reduced male fertility in mice. Despite normal sperm counts, motility, and morphology, the KO sperm were less competitive than wild-type sperm when subjected to a polyandrous mating scheme. Transcriptomic and bioinformatic analyses revealed that these X-linked MIR-506 family miRNAs, in addition to targeting a set of conserved genes, have more targets that are critical for spermatogenesis and embryonic development during evolution. Our data suggest that the MIR-506 family miRNAs function to enhance sperm competitiveness and reproductive fitness of the male by finetuning gene expression during spermatogenesis.